The efficacy and safety of sarilumab, fully human monoclonal antibodies against interleukin 6 receptor, in rheumatoid arthritis: new evidence

by E. L. Nasonov, A. M. Lila
Published 2019-11-01

Seventh Congress of Rheumatologists of Russia with international participation (25–28 April 2017, Moscow)

by E. L. Nasonov, V. N. Amirdzanova
Published 2017-07-01

Chronic pain and central sensitization in immuno-inflammatory rheumatic diseases: pathogenesis, clinical manifestations, the possibility of using targeted disease modifying antirhe...

by A. E. Karateev, E. L. Nasonov
Published 2019-05-01

Janus kinase inhibitors in immuno-inflammatory rheumatic diseases: new opportunities and prospects

by E. L. Nasonov, A. M. Lila
Published 2019-03-01

INHIBITION OF INTERLEUKIN 6 IN IMMUNE INFLAMMATORY RHEUMATIC DISEASES: ACHIEVEMENTS, PROSPECTS, AND HOPES

by E. L. Nasonov, A. M. Lila
Published 2018-01-01

WHY ARE THE RECOMMENDED METHOTREXATE DOSES NOT USED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: WHO IS GUILTY AND WHAT TO DO?

by Yu. V. Muravyev, E. L. Nasonov
Published 2017-03-01

Survival of men with systemic lupus erythematosus

by N G Klyukvina, E L Nasonov
Published 2009-12-01

Rheumatoid arthritis: achievements and unresolved issues

by E L Nasonov, A M Lila
Published 2019-05-01

Seventh Congress of Rheumatologists of Russia with international participation (25–28 April 2017, Moscow)

by E. L. Nasonov, V. N. Amirdzanova
Published 2017-01-01

Reduction of cardiovascular risk in rheumatoid arthritis: double benefit of statins

by Diana Sergeevna Novikova, T V Popkova, E L Nasonov, Diana Sergeyevna Novikova, T V Popkova, E L Nasonov
Published 2010-12-01

Rekomendatsii po snizheniyukardiovaskulyarnogo riska u patsientov s vospalitel'nymi artritami(po materialam rekomendatsiy Evropeyskoy antirevmaticheskoy ligi)

by T V Popkova, D S Novikova, E L Nasonov
Published 2010-03-01

GENNO-INZhENERNYE BIOLOGIChESKIE PREPARATY V TERAPII OSTEOPOROZA U BOL'NYKhREVMATOIDNYM ARTRITOM

by I S DYDYKINA, P S DYDYKINA, E L NASONOV
Published 2013-12-01

IMPACT OF BIOLOGICAL THERAPY ON BONE IN PATIENTS WITH RHEUMATOID ARTHRITIS

by P. S. Dydykina, I. S. Dydykina, E. L. Nasonov
Published 2014-12-01

Problems of early diagnosis of systemic lupus erythematosus during the COVID-19 pandemic

by E. L. Nasonov, T. V. Popkova, T. A. Panafidina
Published 2021-05-01

CARDIOVASCULAR DISEASES IN RHEUMATOID ARTHRITIS: LATEST DATA

by T. V. Popkova, D. S. Novikova, E. L. Nasonov
Published 2016-07-01

USE OF METHOTREXATE IN PATIENTS WITH CALCIUM PYROPHOSPHATE CRYSTAL DEPOSITION DISEASE

by M. S. Eliseev, S. A. Vladimirov, E. L. Nasonov
Published 2018-05-01

Mycophenolate mofetil and atherosclerosis

by Z S Alekberova, T V Popkova, E L Nasonov
Published 2009-10-01

Cardiovascular disease in rheumatic diseases

by E L Nasonov, T V Popkova, D S Novikova
Published 2016-05-01

Perspectives of the treatment of rheumatic diseases in the beginning of the XXI century

by Evgeniy L'vovich Nasonov, E L Nasonov
Published 2011-05-01

Interleukin-6 inhibition and cardiovascular disease in patients with rheumatoid arthritis

by T V Popkova, D S Novikova, E L Nasonov
Published 2016-05-01